Chase AIPricingFAQs
Display currency
Loading news…

R3 Vascular

ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 LowHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 Low growthGrowth score — momentum trend across web traffic, headcount and other growth signals.
Mountain View, California, United States Founded 2019 11-50 employees For Profit

R3 Vascular is a medical device company that develops new therapies to treat peripheral artery disease.

Total Funding
Available in Pro
Last Funding
Available in Pro
Acquisitions
0
Monthly Visits
Available in Pro
Contacts
7
Patents
0
1 trademarks

Company Details

Funding & Financials

Pro
Total funding
Funding rounds
Last funding
Last funding type
Last funding date
Funding status
Total equity funding
Revenue range

IPO & Stock

IPO status
Private

Web Traffic

Pro
Monthly visits
Global traffic rank
6-mo avg visits
Visit duration (s)
Pages / visit
Bounce rate
Rank change (mo)

Technology & IP

Active technologies
20
Patents granted
0
Trademarks
1
IT spend
$288K

Company Info

Founded
2019
Employees
11-50
Operating status
Active
Company type
For Profit
Org types
company
News articles
33
HQ
Mountain View, California, United States
Region
San Francisco Bay Area, Silicon Valley, West Coast

Signals & Scores

Heat score
Low
Growth score
Low
Trend (7d)
0.5
Trend (30d)
1.6
Trend (90d)
2.7
Last leadership hire
Jul 9, 2024

Key People at R3 Vascular

President and CEO
President and CEO
Vice President, Global Clinical and Scientific Affairs
7
professional contacts at R3 Vascular
Contact execs at R3 Vascular

Explore 200,000+ acquisitions — free

Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.

Explore all acquisitions

Recent News related to R3 Vascular

Loading news…

FAQs about R3 Vascular

People who checked this page also checked these

Browse the full Acquirezy directory.
R3 Vascular - Company Profile, Full Acquisitions List, Funding and Investments